effect enalapril neuroendocrin activ prognosi sever congest heart failur follow-up consensu trial consensu trial studi group studi patient sever heart failur new york heart associ function class IV center scandinavia treatment placebo enalapril addit usual treatment heart failur initi titrat period daili dose enalapril end trial placebo-tr patient enalapril-tr patient aliv surviv figur month complet trial follow-up placebo group signific posit associ mortal baselin level norepinephrin epinephrin angiotensin II aldosteron atrial natriuret peptid associ enalapril-tr patient result effect enalapril mortal counteract neuroendocrin activ gener renin-angiotensin system particular 